KCI Protocol # 2011-185 Pilot Trial of oral cabozantinib/ XL184 in metastatic castrate resistant prostate cancer to explore the changes in bone and tumor imaging related pathways Version date: Nov 17 2011, Dec 29, 2011, Mar 19, 2012, June 28, 2012, Sept 6, 2012, Aug 16 2013, June 25, 2014, Aug 14, 2014 Sponsor- NOMIC grant Dept of Defense. Cabozantinib/XL184 and grant support will be provided by Exelixis Inc. IND#: 114758 Principal Investigator: Ulka Vaishampayan M.D. Karmanos Cancer Institute 4100 John R, HW04HO Detroit, MI 48201 Tel # 313-576-8715 Fax # 313-576-8487. E-mail
[email protected] Co-Investigators: Elisabeth Heath M.D. Karmanos Cancer Institute 4100 John R, HW04HO Detroit, MI 48201 Tel# 313-576-8715 Fax # 313-576-8767 Protocol version date Nov 17, 2011, Dec 29, 2011, Mar 19, 2012, June 28, 2012, Sept 6, 2012 Aug 16, 1 2013, June 25, 2014, Aug 14, 2014 E mail
[email protected] Anthony Shields, MD, PhD Associate Cancer Center Director for Clinical Sciences Professor of Oncology Karmanos Cancer Institute 4100 John R, HW04HO Detroit, MI 48201 Office: 313 576 8735 Fax: 313 576 8767 Email:
[email protected] Joseph Fontana M.D. VA Medical Center Oncology 11M-HO Room C3687 4646 John R Detroit MI 48201. Tel# 313-576-3659 E mail
[email protected] Lance Heilbrun Ph.D. Biostatistics Unit Karmanos Cancer Institute 4100 John R, MM05BI Detroit, MI 48201 Detroit, MI 48201. Tel# 313-576-8652 E mail
[email protected] Protocol version date Nov 17, 2011, Dec 29, 2011, Mar 19, 2012, June 28, 2012, Sept 6, 2012 Aug 16, 2 2013, June 25, 2014, Aug 14, 2014 Izabela Podgorski, PhD Assistant Professor Department of Pharmacology Karmanos Cancer Institute, Wayne State University Lab: 313 577 0941 Office: 313 577 0514 E Mail
[email protected] Susan Land PhD Applied Genomics Technology Center CS Mott Center Bldg.